Testing for poor digestion in Alagille syndrome after liver transplant
Part of Digestive system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study looks for signs of poor digestion after a liver transplant in people with Alagille syndrome. You collect stool samples for 3 days while on a high-fat diet to see if your pancreas is making enough enzymes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 7 and 50 years old
- You have a confirmed diagnosis of Alagille syndrome
- You have had a liver transplant because of Alagille syndrome
- You are willing to stop taking pancreatic enzyme pills for 5 days before and during the 3-day stool collection
- You agree to eat a high-fat diet for at least 2 days before and during stool collection and keep a food diary
- You do not have other serious liver diseases, active cancer, or are pregnant/breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with fatty liver disease linked to metabolism. It checks if they also have fat in the pancreas.
This trial tests different doses of a pancreatic enzyme pill to help people who have trouble digesting food after stomach or pancreas surgery. If you've had such surgery and struggle with diarrhea or greasy stools, this study may help improve your digestion.
This trial tests whether pancreatic enzyme supplements can help people with functional dyspepsia, a condition causing ongoing stomach pain or fullness without a clear cause. It is for people who do not have other digestive diseases or H. pylori infection.
This study tests if a new microbial-based pancreatic enzyme works as well as the standard pig-derived enzyme for people with chronic pancreatitis who have trouble digesting food. Participants will take either the new or standard treatment for a period to compare how well it improves digestion and symptoms.
This trial tests whether a fecal (stool) transplant from a healthy donor can help people with both PSC and inflammatory bowel disease. It aims to see if the treatment can improve liver health and reduce inflammation. You must have early to moderate liver scarring and be on stable medications.
This trial tests whether a pancreatic enzyme replacement therapy (PERT) can help people who still have digestive problems after a recent episode of acute pancreatitis. The goal is to see if it improves symptoms like stomach pain, bloating, or diarrhea.
Hear when a new Exocrine Pancreatic Insuficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.